| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(95)90698-3 |
| P698 | PubMed publication ID | 7715293 |
| P2093 | author name string | J J Mekalanos | |
| D T Beattie | |||
| D R Spriggs | |||
| M K Waldor | |||
| D N Taylor | |||
| J C Sadoff | |||
| T S Coster | |||
| K P Killeen | |||
| J R Kenner | |||
| A Trofa | |||
| P2860 | cites work | Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 |
| The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants | Q35912594 | ||
| CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. | Q36262564 | ||
| Live bacterial vaccines: environmental aspects | Q40534875 | ||
| Cholera vaccines: fighting an ancient scourge | Q40695834 | ||
| Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. | Q54695943 | ||
| Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh | Q57924349 | ||
| Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
| Serologic Differentiation Between Antitoxin Responses to Infection with Vibrio cholerae and Enterotoxin-Producing Escherichia coli | Q57925766 | ||
| Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae | Q70313647 | ||
| O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent | Q71600875 | ||
| Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India | Q72212989 | ||
| Non-O1 Vibrio cholerae | Q72227351 | ||
| Vibrio cholerae O139 specific gene sequences | Q72677766 | ||
| P433 | issue | 8955 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| Vibrio cholerae | Q160821 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 949-952 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype | |
| P478 | volume | 345 |
| Q30370187 | A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae. |
| Q35609627 | A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. |
| Q33752525 | A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. |
| Q39877153 | Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells |
| Q33975799 | Active immunization in the United States: developments over the past decade |
| Q35499586 | Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. |
| Q35464775 | Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge |
| Q39516986 | Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells |
| Q29346616 | Characterization of enhancer binding by the Vibrio cholerae flagellar regulatory protein FlrC |
| Q73620155 | Cholera |
| Q30235247 | Cholera. |
| Q35548775 | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains |
| Q39830834 | Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. |
| Q78862034 | Construction and characterisation of O139 cholera vaccine candidates |
| Q39825901 | Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139. |
| Q35088006 | Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine |
| Q46652410 | Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation |
| Q36480147 | Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit |
| Q34005028 | Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision |
| Q36483642 | Decreased potency of the Vibrio cholerae sheathed flagellum to trigger host innate immunity |
| Q35469131 | Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide. |
| Q35526942 | Development of a germfree mouse model of Vibrio cholerae infection. |
| Q39518093 | Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae |
| Q33722821 | Differential regulation of multiple flagellins in Vibrio cholerae |
| Q34009225 | Diminished diarrheal response to Vibrio cholerae strains carrying the replicative form of the CTX(Phi) genome instead of CTX(Phi) lysogens in adult rabbits |
| Q30449794 | Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion |
| Q64074204 | Flagellar Synthesis |
| Q33996336 | Flagellum-independent surface migration of Vibrio cholerae and Escherichia coli |
| Q36191950 | Going against the grain: chemotaxis and infection in Vibrio cholerae |
| Q30432626 | Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage |
| Q36898523 | Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. |
| Q28485730 | In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin |
| Q36227993 | Induction of interleukin-8 in T84 cells by Vibrio cholerae. |
| Q36422323 | Lipidation of an FlrC-dependent protein is required for enhanced intestinal colonization by Vibrio cholerae |
| Q36970778 | Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen. |
| Q36993624 | Metalloprotease vsm is the major determinant of toxicity for extracellular products of Vibrio splendidus |
| Q40695423 | New developments in the understanding of cholera |
| Q37953796 | New-generation vaccines against cholera |
| Q24235775 | Oral vaccines for preventing cholera |
| Q40015233 | PCR-based detection of Vibrio cholerae O139 Bengal with sequences encoding glycosyltransferases |
| Q33732722 | Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor. |
| Q30328099 | Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid |
| Q36670147 | Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium Vibrio cholerae |
| Q30363424 | Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins |
| Q34033623 | Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh |
| Q33942939 | Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139 |
| Q34246068 | Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak |
| Q39290834 | Structural and functional importance of outer membrane proteins in Vibrio cholerae flagellum. |
| Q33998373 | Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis |
| Q37481380 | The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors |
| Q24614429 | The incubation period of cholera: a systematic review |
| Q37523806 | The utility of human challenge studies in vaccine development: lessons learned from cholera |
| Q34757562 | Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae |
| Q39514280 | Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems |
| Q30332762 | Vibrio cholerae O139 Bengal: odyssey of a fortuitous variant |
| Q33598485 | Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice |
| Q30882964 | Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease |
| Q34562952 | Vibrio cholerae: lessons for mucosal vaccine design |
| Q35229428 | Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity |
Search more.